Join Growin Stock Community!

浩泰4131.TW Overview

TW StockBiotech. & Medical
(No presentation for 4131)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

浩泰（4131）Overall Performance

浩泰（4131）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

浩泰（4131） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

浩泰（4131）Key Information

浩泰（4131）Profile

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company's products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and changed its name to NeoCore Technology Co., Ltd. in July 2023. NeoCore Technology Co., Ltd. was founded in 1987 and is headquartered in Tainan, Taiwan.

浩泰（4131）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.52
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
7.83
PB Ratio
4.71
Price-to-FCF
12.92
METRIC
VALUE
vs. INDUSTRY
Gross Margin
34.42%
Net Margin
-10.76%
Revenue Growth (YoY)
194.31%
Profit Growth (YoY)
1354.78%
3-Year Revenue Growth
68.64%
3-Year Profit Growth
150.26%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.52
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
7.83
PB Ratio
4.71
Price-to-FCF
12.92
Gross Margin
34.42%
Net Margin
-10.76%
Revenue Growth (YoY)
194.31%
Profit Growth (YoY)
1354.78%
3-Year Revenue Growth
68.64%
3-Year Profit Growth
150.26%
default symbol

4131

浩泰

37.70D

-0.80%

(-0.01)

  • When is 4131's latest earnings report released?

    The most recent financial report for 浩泰 (4131) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4131's short-term business performance and financial health. For the latest updates on 4131's earnings releases, visit this page regularly.

  • What is the operating profit of 4131?

    According to the latest financial report, 浩泰 (4131) reported an Operating Profit of -18.78M with an Operating Margin of -34.01% this period, representing a decline of 12.71% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4131's revenue growth?

    In the latest financial report, 浩泰 (4131) announced revenue of 55.2M, with a Year-Over-Year growth rate of 234.95%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4131 have?

    At the end of the period, 浩泰 (4131) held Total Cash and Cash Equivalents of 123.6M, accounting for 0.22 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4131 go with three margins increasing?

    In the latest report, 浩泰 (4131) did not achieve the “three margins increasing” benchmark, with a gross margin of 33.94%%, operating margin of -34.01%%, and net margin of -32.88%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4131's profit trajectory and future growth potential.

  • Is 4131's EPS continuing to grow?

    According to the past four quarterly reports, 浩泰 (4131)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.42. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4131?

    浩泰 (4131)'s Free Cash Flow (FCF) for the period is 4.08M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 185.29% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.